tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
Advertisement

Kiniksa Pharmaceuticals (KNSA) Revenue

Compare
480 Followers

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had a revenue of 156.80M in the quarter ending Jun 30, 2025, with 13.80%. This bring the company's revenue in the last twelve months to 529.33M, Decreased 10.01%. In the fiscal year ending Dec 31, 2024, Kiniksa Pharmaceuticals had annual revenue of 423.24M with 56.60% growth.
Revenue (ttm)
529.33M
Revenue Growth
56.18%
P/S Ratio
5.60
Revenue/Employee
$1,343,616
Employees
315
Market Cap
$2.37B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
423.24M152.98M+56.60%
Dec 31, 2023
270.26M50.08M+22.74%
Dec 31, 2022
220.18M181.64M+471.24%
Dec 31, 2021
38.54M+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis